Natera Beheer
Beheer criteriumcontroles 3/4
De CEO Natera is Steve Chapman, benoemd in Jan2019, heeft een ambtstermijn van 5.83 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 12.73M, bestaande uit 5.9% salaris en 94.1% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.021% van de aandelen van het bedrijf, ter waarde $ 4.57M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 5.8 jaar en 7.7 jaar.
Belangrijke informatie
Steve Chapman
Algemeen directeur
US$12.7m
Totale compensatie
| Percentage CEO-salaris | 5.9% |
| Dienstverband CEO | 5.8yrs |
| Eigendom CEO | 0.02% |
| Management gemiddelde ambtstermijn | 5.8yrs |
| Gemiddelde ambtstermijn bestuur | 7.7yrs |
Recente managementupdates
Recent updates
Subdued Growth No Barrier To Natera, Inc. (NASDAQ:NTRA) With Shares Advancing 25%
Nov 19
Natera, Inc. (NASDAQ:NTRA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$158
Nov 15Natera And GeneDx: Outperforming Market Powered By Precision Medicines Tailwinds
Oct 31Natera, Inc.'s (NASDAQ:NTRA) Intrinsic Value Is Potentially 20% Below Its Share Price
Sep 18Does Natera (NASDAQ:NTRA) Have A Healthy Balance Sheet?
Jul 05Natera: Overdue For A Breather
Jun 03Natera, Inc. (NASDAQ:NTRA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$119
May 12Is There An Opportunity With Natera, Inc.'s (NASDAQ:NTRA) 41% Undervaluation?
Mar 30Natera: Capitalizing On The Positive Momentum Of Personalized Medicine
Mar 22Is Natera (NASDAQ:NTRA) A Risky Investment?
Mar 03Estimating The Fair Value Of Natera, Inc. (NASDAQ:NTRA)
Dec 11Is Natera (NASDAQ:NTRA) A Risky Investment?
Nov 10Natera, Inc. (NASDAQ:NTRA) Shares Could Be 46% Below Their Intrinsic Value Estimate
Aug 07Health Check: How Prudently Does Natera (NASDAQ:NTRA) Use Debt?
May 16Natera, Inc.'s (NASDAQ:NTRA) Low P/S No Reason For Excitement
Apr 18Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$215m |
| Jun 30 2024 | n/a | n/a | -US$292m |
| Mar 31 2024 | n/a | n/a | -US$365m |
| Dec 31 2023 | US$13m | US$751k | -US$435m |
| Sep 30 2023 | n/a | n/a | -US$499m |
| Jun 30 2023 | n/a | n/a | -US$512m |
| Mar 31 2023 | n/a | n/a | -US$546m |
| Dec 31 2022 | US$8m | US$610k | -US$548m |
| Sep 30 2022 | n/a | n/a | -US$546m |
| Jun 30 2022 | n/a | n/a | -US$576m |
| Mar 31 2022 | n/a | n/a | -US$546m |
| Dec 31 2021 | US$23m | US$526k | -US$472m |
| Sep 30 2021 | n/a | n/a | -US$408m |
| Jun 30 2021 | n/a | n/a | -US$315m |
| Mar 31 2021 | n/a | n/a | -US$258m |
| Dec 31 2020 | US$8m | US$487k | -US$230m |
| Sep 30 2020 | n/a | n/a | -US$189m |
| Jun 30 2020 | n/a | n/a | -US$153m |
| Mar 31 2020 | n/a | n/a | -US$126m |
| Dec 31 2019 | US$6m | US$451k | -US$125m |
| Sep 30 2019 | n/a | n/a | -US$121m |
| Jun 30 2019 | n/a | n/a | -US$128m |
| Mar 31 2019 | n/a | n/a | -US$129m |
| Dec 31 2018 | US$1m | US$373k | -US$128m |
| Sep 30 2018 | n/a | n/a | -US$144m |
| Jun 30 2018 | n/a | n/a | -US$142m |
| Mar 31 2018 | n/a | n/a | -US$137m |
| Dec 31 2017 | US$2m | US$369k | -US$138m |
Compensatie versus markt: De totale vergoeding ($USD 12.73M ) Steve } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 12.73M ).
Compensatie versus inkomsten: De vergoeding van Steve is gestegen terwijl het bedrijf verliesgevend is.
CEO
Steve Chapman (45 yo)
5.8yrs
Tenure
US$12,727,887
Compensatie
Mr. Steven Leonard Chapman, also known as Steve, has been Chief Executive Officer and Director at Natera, Inc. since January 02, 2019. He served as President at Natera, Inc. since January 02, 2019. Mr. Cha...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 19.8yrs | US$8.97m | 1.89% $ 419.7m | |
| CEO & Director | 5.8yrs | US$12.73m | 0.021% $ 4.6m | |
| Chief Financial Officer | 7.8yrs | US$5.07m | 0.0072% $ 1.6m | |
| Secretary & Chief Legal Officer | no data | US$3.33m | 0.12% $ 27.1m | |
| President & Chief Business Officer | 1.2yrs | geen gegevens | 0.041% $ 9.0m | |
| Co-Founder & Director | no data | US$657.99k | 0.26% $ 57.5m | |
| Chief Accounting Officer | 2.7yrs | geen gegevens | geen gegevens | |
| Chief Technology Officer | no data | geen gegevens | geen gegevens | |
| Chief Scientific Officer | 4.8yrs | geen gegevens | geen gegevens | |
| Chief Compliance & Privacy Officer | 7.3yrs | geen gegevens | geen gegevens | |
| Vice President of Sales | 8.7yrs | geen gegevens | geen gegevens | |
| President of Clinical Diagnostics | no data | geen gegevens | 0.017% $ 3.8m |
5.8yrs
Gemiddelde duur
45yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van NTRA is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.8 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 19.8yrs | US$8.97m | 1.89% $ 419.7m | |
| CEO & Director | 5.8yrs | US$12.73m | 0.021% $ 4.6m | |
| Co-Founder & Director | 17.8yrs | US$657.99k | 0.26% $ 57.5m | |
| Independent Director | 10yrs | US$329.64k | 0.033% $ 7.2m | |
| Independent Director | 7.8yrs | US$339.16k | 0.047% $ 10.5m | |
| Lead Independent Director | 17.8yrs | US$350.98k | 0.99% $ 220.4m | |
| Independent Director | 7.7yrs | US$337.22k | 0.012% $ 2.7m | |
| Independent Director | 5.3yrs | US$338.72k | 0.0035% $ 777.9k | |
| Independent Director | 6.3yrs | US$317.73k | 0.0097% $ 2.2m | |
| Independent Director | 1.7yrs | US$433.44k | geen gegevens |
7.7yrs
Gemiddelde duur
56yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van NTRA wordt beschouwd als ervaren (gemiddelde ambtstermijn 7.7 jaar).